Product peg-derivatives -peptide-pegs

Home > products > peg-derivatives > peptide-pegs

Catalog	name	Description	price
R-M2-9799	GGG-PEG3-N3	GGG-PEG3-N3/Gly-Gly-Gly-PEG3-Azide is a modular linker used in click chemistry, bioconjugation, and site-selective surface modifications and peptide-based materials, surface tagging, or nanoconjugate development.	price>
R-M2-9810	CHOL-PEG2K-SFHQFARATLAS	CHOL-PEG2K-SFHQFARATLAS/Cholesterol-PEG2K-SFHQFARATLAS is a cholesterol–PEG–peptide conjugate.SFHQFARATLAS (Peptide):A 12-amino acid sequence (Ser–Phe–His–Gln–Phe–Ala–Arg–Ala–Thr–Leu–Ala–Ser), potentially functioning as a targeting ligand, cell-penetrating sequence, or bioactive peptide. Applications: Targeted liposomal drug delivery systems; Nanoparticle surface modification for site-specific delivery; Peptide-mediated cellular uptake enhancement; Diagnostic or therapeutic nanocarriers.	price>
R-M2-9811	DMG-PEG2K-SFHQFARATLAS	DMG-PEG2K-SFHQFARATLAS is a peptide conjugate. Applications: Targeted liposomal delivery systems (e.g., for drugs, siRNA, or imaging agents); Nanoparticle surface functionalization for enhanced selectivity; Theranostic carriers combining therapy and imaging; Peptide-mediated endocytosis or receptor binding.	price>
R-M2-9812	CHOL-PEG5K-GPC3(PHLASLWWGTEL)	CHOL-PEG5K-GPC3 Targeted Peptide (PHLASLWWGTEL)/Cholesterol-PEG5K-GPC3 Targeted Peptide(PHLASLWWGTEL)/Cholesterol-PEG5K-GPC3(PHLASLWWGTEL)/Cholesterol-PEG5K-PHLASLWWGTEL is a cholesterol-PEG-peptide conjugate designed for targeted delivery. Applications: Targeted liposomal drug delivery for liver cancer (HCC). Diagnostic imaging probes targeting GPC3-overexpressing tissues. Theranostic carriers combining therapy and imaging in HCC. Can be used to deliver siRNA, chemotherapeutics, or photosensitizers selectively to tumor cells.	price>
R-M2-9813	DMG-PEG5K-GPC3(PHLASLWWGTEL)	DMG-PEG5K-GPC3 Targeted Peptide (PHLASLWWGTEL)/DMG-PEG5K-GPC3 Targeted Peptide(PHLASLWWGTEL)/DMG-PEG5K-GPC3(PHLASLWWGTEL) is a peptide conjugate designed for targeted delivery. Applications: Targeted liposomal drug delivery for liver cancer (HCC). Diagnostic imaging probes targeting GPC3-overexpressing tissues. Theranostic carriers combining therapy and imaging in HCC. Can be used to deliver siRNA, chemotherapeutics, or photosensitizers selectively to tumor cells.	price>
R-M1-8215	Cholesterol-PEG-FCIGRLGGGGGGC	Cholesterol-PEG-FCIGRLGGGGGGC is a bifunctional peptide modified peg reagent.	price>
R-M1-8221	DMG-PEG2K-PKTRNSQTQTDRRRRRRRR	DMG-PEG2K-PKTRNSQTQTDRRRRRRRR is a Peptide modified heterobifunctional peg reagent.	price>
R-M2-9863	DMG-PEG-THRPPMWSPVWP	DMG-PEG-THRPPMWSPVWP is a peptide conjugate.This amphiphilic construct allows stable incorporation into liposomal or nanoparticle systems, providing both biocompatibility and active targeting functionality. Applications: Targeted liposomal drug delivery with enhanced selectivity. Nanoparticle surface functionalization for receptor-mediated uptake. Cellular imaging or diagnostic probes when combined with fluorescent or therapeutic cargo. Theranostic nanomedicine integrating targeting, imaging, and therapy.	price>
R-M2-9864	CHOL-PEG-THRPPMWSPVWP	CHOL-PEG-THRPPMWSPVWP/Cholesterol-polyethylene glycol-THRPPMWSPVWP is a peptide conjugate.The cholesterol moiety enables stable insertion into lipid bilayers or micelles, while PEG provides hydrophilicity and steric stabilization, and the THRPPMWSPVWP sequence acts as a targeting peptide (often used to recognize tumor or disease-related receptors). Applications: Targeted drug delivery (liposomes, micelles, exosomes). Theranostic nanoparticles for tumor imaging and therapy. Surface functionalization of lipid or polymeric carriers to improve cell-specific uptake.	price>
R-M2-9865	DMG-PEG-THRPPMWSPVWP-NH2	DMG-PEG-THRPPMWSPVWP-NH2 is a peptide conjugate. Applications: Targeted liposomal drug delivery (smallmolecules, siRNA, peptides). Theranostic nanocarriers with imaging agent attachment. SurfaceDMG-PEG-THRPPMWSPVWP-NH2 is a peptide conjugate. Applications: Targeted liposomal drug delivery (smallmolecules, siRNA, peptides). Theranostic nanocarriers with imaging agent attachment. Surface functionalization of liposomes, polymersomes, or hybrid nanoparticles. functionalization of liposomes, polymersomes, or hybrid nanoparticles.	price>

...